Cargando…

First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats

SIMPLE SUMMARY: Proton minibeam radiation therapy (pMBRT) is a novel therapeutic approach based on a distinct dose delivery method: the dose distributions follow a pattern with regions of peaks (high doses) and valleys (low doses). pMBRT was shown to be able to widen the therapeutic window in glioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertho, Annaïg, Ortiz, Ramon, Juchaux, Marjorie, Gilbert, Cristèle, Lamirault, Charlotte, Pouzoulet, Frederic, Polledo, Laura, Liens, Alethea, Warfving, Nils, Sebrie, Catherine, Jourdain, Laurène, Patriarca, Annalisa, de Marzi, Ludovic, Prezado, Yolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507607/
https://www.ncbi.nlm.nih.gov/pubmed/34638352
http://dx.doi.org/10.3390/cancers13194865
_version_ 1784581892234805248
author Bertho, Annaïg
Ortiz, Ramon
Juchaux, Marjorie
Gilbert, Cristèle
Lamirault, Charlotte
Pouzoulet, Frederic
Polledo, Laura
Liens, Alethea
Warfving, Nils
Sebrie, Catherine
Jourdain, Laurène
Patriarca, Annalisa
de Marzi, Ludovic
Prezado, Yolanda
author_facet Bertho, Annaïg
Ortiz, Ramon
Juchaux, Marjorie
Gilbert, Cristèle
Lamirault, Charlotte
Pouzoulet, Frederic
Polledo, Laura
Liens, Alethea
Warfving, Nils
Sebrie, Catherine
Jourdain, Laurène
Patriarca, Annalisa
de Marzi, Ludovic
Prezado, Yolanda
author_sort Bertho, Annaïg
collection PubMed
description SIMPLE SUMMARY: Proton minibeam radiation therapy (pMBRT) is a novel therapeutic approach based on a distinct dose delivery method: the dose distributions follow a pattern with regions of peaks (high doses) and valleys (low doses). pMBRT was shown to be able to widen the therapeutic window in glioma-bearing rats. In previous studies the irradiation was performed in one single fraction. The work reported in this manuscript is the first evaluation detailing the response of glioma-bearing rats to a temporal fractionation in proton minibeam radiation therapy, delivered under a crossfire geometry. A significant increase of the median survival time was obtained when the dose was delivered over two sessions as opposed to in a single fraction. This result could facilitate the path towards pMBRT treatments. ABSTRACT: (1) Background: Proton minibeam radiation therapy (pMBRT) is a new radiotherapy technique using spatially modulated narrow proton beams. pMBRT results in a significantly reduced local tissue toxicity while maintaining or even increasing the tumor control efficacy as compared to conventional radiotherapy in small animal experiments. In all the experiments performed up to date in tumor bearing animals, the dose was delivered in one single fraction. This is the first assessment on the impact of a temporal fractionation scheme on the response of glioma-bearing animals to pMBRT. (2) Methods: glioma-bearing rats were irradiated with pMBRT using a crossfire geometry. The response of the irradiated animals in one and two fractions was compared. An additional group of animals was also treated with conventional broad beam irradiations. (3) Results: pMBRT delivered in two fractions at the biological equivalent dose corresponding to one fraction resulted in the highest median survival time, with 80% long-term survivors free of tumors. No increase in local toxicity was noted in this group with respect to the other pMBRT irradiated groups. Conventional broad beam irradiations resulted in the most severe local toxicity. (4) Conclusion: Temporal fractionation increases the therapeutic index in pMBRT and could ease the path towards clinical trials.
format Online
Article
Text
id pubmed-8507607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85076072021-10-13 First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats Bertho, Annaïg Ortiz, Ramon Juchaux, Marjorie Gilbert, Cristèle Lamirault, Charlotte Pouzoulet, Frederic Polledo, Laura Liens, Alethea Warfving, Nils Sebrie, Catherine Jourdain, Laurène Patriarca, Annalisa de Marzi, Ludovic Prezado, Yolanda Cancers (Basel) Article SIMPLE SUMMARY: Proton minibeam radiation therapy (pMBRT) is a novel therapeutic approach based on a distinct dose delivery method: the dose distributions follow a pattern with regions of peaks (high doses) and valleys (low doses). pMBRT was shown to be able to widen the therapeutic window in glioma-bearing rats. In previous studies the irradiation was performed in one single fraction. The work reported in this manuscript is the first evaluation detailing the response of glioma-bearing rats to a temporal fractionation in proton minibeam radiation therapy, delivered under a crossfire geometry. A significant increase of the median survival time was obtained when the dose was delivered over two sessions as opposed to in a single fraction. This result could facilitate the path towards pMBRT treatments. ABSTRACT: (1) Background: Proton minibeam radiation therapy (pMBRT) is a new radiotherapy technique using spatially modulated narrow proton beams. pMBRT results in a significantly reduced local tissue toxicity while maintaining or even increasing the tumor control efficacy as compared to conventional radiotherapy in small animal experiments. In all the experiments performed up to date in tumor bearing animals, the dose was delivered in one single fraction. This is the first assessment on the impact of a temporal fractionation scheme on the response of glioma-bearing animals to pMBRT. (2) Methods: glioma-bearing rats were irradiated with pMBRT using a crossfire geometry. The response of the irradiated animals in one and two fractions was compared. An additional group of animals was also treated with conventional broad beam irradiations. (3) Results: pMBRT delivered in two fractions at the biological equivalent dose corresponding to one fraction resulted in the highest median survival time, with 80% long-term survivors free of tumors. No increase in local toxicity was noted in this group with respect to the other pMBRT irradiated groups. Conventional broad beam irradiations resulted in the most severe local toxicity. (4) Conclusion: Temporal fractionation increases the therapeutic index in pMBRT and could ease the path towards clinical trials. MDPI 2021-09-28 /pmc/articles/PMC8507607/ /pubmed/34638352 http://dx.doi.org/10.3390/cancers13194865 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bertho, Annaïg
Ortiz, Ramon
Juchaux, Marjorie
Gilbert, Cristèle
Lamirault, Charlotte
Pouzoulet, Frederic
Polledo, Laura
Liens, Alethea
Warfving, Nils
Sebrie, Catherine
Jourdain, Laurène
Patriarca, Annalisa
de Marzi, Ludovic
Prezado, Yolanda
First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats
title First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats
title_full First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats
title_fullStr First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats
title_full_unstemmed First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats
title_short First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats
title_sort first evaluation of temporal and spatial fractionation in proton minibeam radiation therapy of glioma-bearing rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507607/
https://www.ncbi.nlm.nih.gov/pubmed/34638352
http://dx.doi.org/10.3390/cancers13194865
work_keys_str_mv AT berthoannaig firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT ortizramon firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT juchauxmarjorie firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT gilbertcristele firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT lamiraultcharlotte firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT pouzouletfrederic firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT polledolaura firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT liensalethea firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT warfvingnils firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT sebriecatherine firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT jourdainlaurene firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT patriarcaannalisa firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT demarziludovic firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats
AT prezadoyolanda firstevaluationoftemporalandspatialfractionationinprotonminibeamradiationtherapyofgliomabearingrats